{"product_id":"bronchogen-20mg-vial","title":"Bronchogen 20mg vial","description":"\u003cp data-end=\"98\" data-start=\"0\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e                                              \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003eFOR HUMAN CONSUMPTION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2 data-end=\"98\" data-start=\"0\"\u003eBronchogen (AEDL): synthesized “bronchopulmonary” bioregulator tetrapeptide \u003c\/h2\u003e\n\u003cp data-end=\"378\" data-start=\"100\"\u003e\u003cbr data-end=\"117\" data-start=\"114\"\u003e\u003cstrong data-end=\"131\" data-start=\"117\"\u003eBronchogen\u003c\/strong\u003e is most commonly described as an \u003cstrong data-end=\"221\" data-start=\"165\"\u003eultrashort, organ-targeted bioregulator tetrapeptide\u003c\/strong\u003e with the sequence \u003cstrong data-end=\"277\" data-start=\"240\"\u003eAla-Glu-Asp-Leu (AEDL; H-AEDL-OH)\u003c\/strong\u003e, associated with the Khavinson peptide bioregulator framework. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"685\" data-start=\"380\"\u003e\u003cstrong data-end=\"396\" data-start=\"380\"\u003eCore concept\u003c\/strong\u003e\u003cbr data-end=\"399\" data-start=\"396\"\u003eRather than acting as a classic receptor agonist, Bronchogen is proposed to \u003cstrong data-end=\"519\" data-start=\"475\"\u003eenter cells and modulate gene expression\u003c\/strong\u003e in a tissue-biased manner, with particular focus on \u003cstrong data-end=\"646\" data-start=\"572\"\u003ebronchial epithelium \/ lung functional maintenance and repair programs\u003c\/strong\u003e. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"922\" data-start=\"687\"\u003e\u003cstrong data-end=\"708\" data-start=\"687\"\u003eRegulatory status\u003c\/strong\u003e\u003cbr data-end=\"711\" data-start=\"708\"\u003eAs sold in “bioregulator\/research peptide” channels, Bronchogen is \u003cstrong data-end=\"816\" data-start=\"778\"\u003enot FDA\/EMA-approved as a medicine\u003c\/strong\u003e; clinical claims therefore do not have drug-label-grade validation. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"927\" data-start=\"924\"\u003e\n\u003ch2 data-end=\"1005\" data-start=\"929\"\u003e1) Additional benefits now under investigation (Bronchogen\/AEDL-centered)\u003c\/h2\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"2279\" data-start=\"1007\"\u003e\n\u003cthead data-end=\"1035\" data-start=\"1007\"\u003e\n\u003ctr data-end=\"1035\" data-start=\"1007\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"1017\" data-start=\"1007\"\u003eBENEFIT\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"1035\" data-start=\"1017\"\u003eKEY TAKE-AWAYS\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"2279\" data-start=\"1046\"\u003e\n\u003ctr data-end=\"1390\" data-start=\"1046\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1103\" data-start=\"1046\"\u003e1) Airway epithelial support (mucins\/surfactant genes)\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1390\" data-start=\"1103\"\u003eA systematic review on peptide gene regulation reports \u003cstrong data-end=\"1217\" data-start=\"1160\"\u003eAEDL activates expression of MUC4, MUC5AC, and SFTPA1\u003c\/strong\u003e, genes relevant to airway mucosal protection and surfactant biology (and noted as decreased in bronchopulmonary pathology contexts). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1708\" data-start=\"1391\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1439\" data-start=\"1391\"\u003e2) “Normalization” of lung function in models\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1708\" data-start=\"1439\"\u003eA conference\/white-paper style PDF describes \u003cstrong data-end=\"1499\" data-start=\"1486\"\u003eADEL\/AEDL\u003c\/strong\u003e as restoring lung function across experimental pathologies, including models of \u003cstrong data-end=\"1653\" data-start=\"1580\"\u003eacute bacterial inflammation, chronic fibrosis, and toxic lung injury\u003c\/strong\u003e (preclinical). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2007\" data-start=\"1709\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1753\" data-start=\"1709\"\u003e3) DNA \/ chromatin interaction hypothesis\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2007\" data-start=\"1753\"\u003eMultiple sources discuss AEDL as influencing nucleic-acid stability (e.g., \u003cstrong data-end=\"1853\" data-start=\"1830\"\u003eDNA thermostability\u003c\/strong\u003efindings reported in microcalorimetry-type studies), used as a mechanistic rationale for transcriptional effects. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2279\" data-start=\"2008\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2066\" data-start=\"2008\"\u003e4) Respiratory inflammation modulation (broadly framed)\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2279\" data-start=\"2066\"\u003eCommercial\/secondary summaries hypothesize reduced inflammation and improved repair, but these are \u003cstrong data-end=\"2182\" data-start=\"2167\"\u003einferential\u003c\/strong\u003e and not equivalent to controlled clinical outcome proof. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp data-end=\"2596\" data-start=\"2281\"\u003e\u003cstrong data-end=\"2307\" data-start=\"2281\"\u003eEvidence quality note:\u003c\/strong\u003e The strongest “hard” items you can cite are \u003cstrong data-end=\"2390\" data-start=\"2352\"\u003egene-expression modulation reports\u003c\/strong\u003e and \u003cstrong data-end=\"2427\" data-start=\"2395\"\u003epreclinical model statements\u003c\/strong\u003e; high-quality, widely indexed \u003cstrong data-end=\"2484\" data-start=\"2458\"\u003ehuman RCT outcome data\u003c\/strong\u003e for Bronchogen itself are not clearly established from the sources above. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"2601\" data-start=\"2598\"\u003e\n\u003ch2 data-end=\"2638\" data-start=\"2603\"\u003e2) Molecular mechanism of action\u003c\/h2\u003e\n\u003ch3 data-end=\"2703\" data-start=\"2640\"\u003e2.1 “Pharmacodynamics” framing (how it’s usually described)\u003c\/h3\u003e\n\u003cp data-end=\"2774\" data-start=\"2704\"\u003eBronchogen is framed as an \u003cstrong data-end=\"2764\" data-start=\"2731\"\u003eultrashort regulatory peptide\u003c\/strong\u003e that may:\u003c\/p\u003e\n\u003cul data-end=\"3013\" data-start=\"2775\"\u003e\n\u003cli data-end=\"2886\" data-start=\"2775\"\u003e\n\u003cp data-end=\"2886\" data-start=\"2777\"\u003einteract with \u003cstrong data-end=\"2819\" data-start=\"2791\"\u003enuclear\/chromatin-linked\u003c\/strong\u003e processes (via nucleic-acid stability\/interaction findings), and\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3013\" data-start=\"2887\"\u003e\n\u003cp data-end=\"3013\" data-start=\"2889\"\u003eshift \u003cstrong data-end=\"2941\" data-start=\"2895\"\u003eairway epithelial transcriptional programs\u003c\/strong\u003e related to mucins and surfactant. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"3069\" data-start=\"3015\"\u003e2.2 Down-stream biology (reported\/claimed signals)\u003c\/h3\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"3697\" data-start=\"3070\"\u003e\n\u003cthead data-end=\"3121\" data-start=\"3070\"\u003e\n\u003ctr data-end=\"3121\" data-start=\"3070\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3089\" data-start=\"3070\"\u003ePATHWAY \/ DOMAIN\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"3110\" data-start=\"3089\"\u003eFUNCTIONAL OUTCOME\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"3121\" data-start=\"3110\"\u003eCONTEXT\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3697\" data-start=\"3136\"\u003e\n\u003ctr data-end=\"3321\" data-start=\"3136\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3175\" data-start=\"3136\"\u003eBronchial epithelium gene expression\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3241\" data-start=\"3175\"\u003e↑ \u003cstrong data-end=\"3187\" data-start=\"3179\"\u003eMUC4\u003c\/strong\u003e, ↑ \u003cstrong data-end=\"3201\" data-start=\"3191\"\u003eMUC5AC\u003c\/strong\u003e, ↑ \u003cstrong data-end=\"3215\" data-start=\"3205\"\u003eSFTPA1\u003c\/strong\u003e transcription (reported)\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3321\" data-start=\"3241\"\u003eairway protection + surfactant biology \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3523\" data-start=\"3322\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3354\" data-start=\"3322\"\u003eDNA physicochemical stability\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3434\" data-start=\"3354\"\u003e↑ DNA melting temperature \/ thermostability (reported in experimental setups)\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3523\" data-start=\"3434\"\u003eproposed transcriptional modulation rationale \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3697\" data-start=\"3524\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3549\" data-start=\"3524\"\u003eInjury model phenotype\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3627\" data-start=\"3549\"\u003eimproved lung function across inflammatory\/fibrotic\/toxic models (reported)\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3697\" data-start=\"3627\"\u003epreclinical disease models \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3702\" data-start=\"3699\"\u003e\n\u003ch2 data-end=\"3726\" data-start=\"3704\"\u003e3) Pharmacokinetics\u003c\/h2\u003e\n\u003cp data-end=\"4160\" data-start=\"3727\"\u003eThere is \u003cstrong data-end=\"3778\" data-start=\"3736\"\u003eno authoritative drug-label PK profile\u003c\/strong\u003e for Bronchogen in the common “research\/bioregulator” marketplace. As an \u003cstrong data-end=\"3878\" data-start=\"3851\"\u003eunmodified tetrapeptide\u003c\/strong\u003e, systemic exposure would generally be expected to be \u003cstrong data-end=\"3970\" data-start=\"3932\"\u003ehighly route\/formulation dependent\u003c\/strong\u003eand subject to \u003cstrong data-end=\"4017\" data-start=\"3986\"\u003erapid peptidase degradation\u003c\/strong\u003e—which is why many discussions focus on mechanistic plausibility rather than exposure-validated dosing. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"4165\" data-start=\"4162\"\u003e\n\u003ch2 data-end=\"4207\" data-start=\"4167\"\u003e4) Pre-clinical and clinical evidence\u003c\/h2\u003e\n\u003ch3 data-end=\"4253\" data-start=\"4209\"\u003e4.1 Mechanistic \/ preclinical (stronger)\u003c\/h3\u003e\n\u003cul data-end=\"4819\" data-start=\"4254\"\u003e\n\u003cli data-end=\"4439\" data-start=\"4254\"\u003e\n\u003cp data-end=\"4439\" data-start=\"4256\"\u003eReview-level reporting that \u003cstrong data-end=\"4343\" data-start=\"4284\"\u003eAEDL regulates bronchial epithelial functional activity\u003c\/strong\u003e and activates \u003cstrong data-end=\"4380\" data-start=\"4358\"\u003eMUC4\/MUC5AC\/SFTPA1\u003c\/strong\u003e gene expression. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4682\" data-start=\"4440\"\u003e\n\u003cp data-end=\"4682\" data-start=\"4442\"\u003ePreclinical model claims in institute-affiliated PDF material: \u003cstrong data-end=\"4542\" data-start=\"4505\"\u003eacute bacterial lung inflammation\u003c\/strong\u003e, \u003cstrong data-end=\"4564\" data-start=\"4544\"\u003echronic fibrosis\u003c\/strong\u003e, and \u003cstrong data-end=\"4602\" data-start=\"4570\"\u003esub-lethal toxic lung damage\u003c\/strong\u003e models showing benefit\/normalization. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4819\" data-start=\"4683\"\u003e\n\u003cp data-end=\"4819\" data-start=\"4685\"\u003eDNA interaction\/thermostability findings used to support chromatin\/transcription hypotheses. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"4871\" data-start=\"4821\"\u003e4.2 Human clinical evidence (weaker \/ unclear)\u003c\/h3\u003e\n\u003cp data-end=\"5229\" data-start=\"4872\"\u003eFrom the sources retrieved here, \u003cstrong data-end=\"4942\" data-start=\"4905\"\u003erobust, widely indexed human RCTs\u003c\/strong\u003e demonstrating clear clinical endpoints (e.g., COPD exacerbations, spirometry outcomes, validated symptom\/QoL scales) for Bronchogen are \u003cstrong data-end=\"5106\" data-start=\"5079\"\u003enot clearly established\u003c\/strong\u003e; many “lung health” claims are extrapolated from preclinical and mechanistic work. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"5234\" data-start=\"5231\"\u003e\n\u003ch2 data-end=\"5269\" data-start=\"5236\"\u003e5) Emerging clinical interests\u003c\/h2\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"5664\" data-start=\"5270\"\u003e\n\u003cthead data-end=\"5300\" data-start=\"5270\"\u003e\n\u003ctr data-end=\"5300\" data-start=\"5270\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"5278\" data-start=\"5270\"\u003eFIELD\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5290\" data-start=\"5278\"\u003eRATIONALE\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5300\" data-start=\"5290\"\u003eSTATUS\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"5664\" data-start=\"5315\"\u003e\n\u003ctr data-end=\"5500\" data-start=\"5315\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5361\" data-start=\"5315\"\u003eChronic airway disease support (conceptual)\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5413\" data-start=\"5361\"\u003eepithelial transcription + mucin\/surfactant genes\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5500\" data-start=\"5413\"\u003eearly mechanistic\/preclinical; needs trials \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5664\" data-start=\"5501\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5539\" data-start=\"5501\"\u003eFibrosis biology adjunct hypothesis\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5579\" data-start=\"5539\"\u003emodel claims in fibrosis\/toxic injury\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5664\" data-start=\"5579\"\u003epreclinical claims; translation uncertain \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"5669\" data-start=\"5666\"\u003e\n\u003ch2 data-end=\"5700\" data-start=\"5671\"\u003e6) Safety and tolerability\u003c\/h2\u003e\n\u003cp data-end=\"5925\" data-start=\"5701\"\u003e\u003cstrong data-end=\"5730\" data-start=\"5701\"\u003eHigh-certainty statement:\u003c\/strong\u003e Bronchogen is not distributed with an FDA\/EMA medication label in typical bioregulator\/research markets, so \u003cstrong data-end=\"5924\" data-start=\"5839\"\u003econtraindications, interactions, and monitoring are not defined to drug standards\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"5956\" data-start=\"5927\"\u003eMain real-world risk drivers:\u003c\/p\u003e\n\u003cul data-end=\"6306\" data-start=\"5957\"\u003e\n\u003cli data-end=\"6126\" data-start=\"5957\"\u003e\n\u003cp data-end=\"6126\" data-start=\"5959\"\u003e\u003cstrong data-end=\"6000\" data-start=\"5959\"\u003ePurity\/identity\/sterility variability\u003c\/strong\u003e across non-pharmaceutical suppliers (especially for injectable research materials). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6306\" data-start=\"6127\"\u003e\n\u003cp data-end=\"6306\" data-start=\"6129\"\u003e\u003cstrong data-end=\"6163\" data-start=\"6129\"\u003eImmunologic or local reactions\u003c\/strong\u003e are possible with peptide products; risk depends heavily on route\/formulation and quality controls (often unknown outside regulated products).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"6311\" data-start=\"6308\"\u003e\n\u003ch2 data-end=\"6339\" data-start=\"6313\"\u003e7) Regulatory landscape\u003c\/h2\u003e\n\u003cul data-end=\"6506\" data-start=\"6340\"\u003e\n\u003cli data-end=\"6506\" data-start=\"6340\"\u003e\n\u003cp data-end=\"6506\" data-start=\"6342\"\u003eCommonly positioned as \u003cstrong data-end=\"6390\" data-start=\"6365\"\u003eresearch\/bioregulator\u003c\/strong\u003e material rather than an approved therapeutic with standardized indications. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"6511\" data-start=\"6508\"\u003e\n\u003ch2 data-end=\"6565\" data-start=\"6513\"\u003e8) Future directions (what would validate claims)\u003c\/h2\u003e\n\u003col data-end=\"7083\" data-start=\"6566\"\u003e\n\u003cli data-end=\"6704\" data-start=\"6566\"\u003e\n\u003cp data-end=\"6704\" data-start=\"6569\"\u003e\u003cstrong data-end=\"6593\" data-start=\"6569\"\u003eGMP-grade definition\u003c\/strong\u003e (confirmed sequence, impurities, stability; lot-to-lot consistency). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6885\" data-start=\"6705\"\u003e\n\u003cp data-end=\"6885\" data-start=\"6708\"\u003e\u003cstrong data-end=\"6732\" data-start=\"6708\"\u003eHuman PK\/PD bridging\u003c\/strong\u003e: demonstrate tissue exposure and reproducible biomarker shifts (e.g., mucin\/surfactant expression signatures). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7034\" data-start=\"6886\"\u003e\n\u003cp data-end=\"7034\" data-start=\"6889\"\u003e\u003cstrong data-end=\"6919\" data-start=\"6889\"\u003eControlled clinical trials\u003c\/strong\u003e with hard endpoints (spirometry, exacerbation frequency, validated dyspnea\/QoL, imaging\/biomarkers in fibrosis).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7083\" data-start=\"7035\"\u003e\n\u003cp data-end=\"7083\" data-start=\"7038\"\u003e\u003cstrong data-end=\"7057\" data-start=\"7038\"\u003eSafety datasets\u003c\/strong\u003e adequate for chronic use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"7088\" data-start=\"7085\"\u003e\n\u003ch2 data-end=\"7112\" data-start=\"7090\"\u003eSelected references\u003c\/h2\u003e\n\u003cul data-end=\"7593\" data-start=\"7113\"\u003e\n\u003cli data-end=\"7209\" data-start=\"7113\"\u003e\n\u003cp data-end=\"7209\" data-start=\"7115\"\u003eBronchogen sequence \u003cstrong data-end=\"7166\" data-start=\"7135\"\u003eH-Ala-Glu-Asp-Leu-OH (AEDL)\u003c\/strong\u003e: \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7345\" data-start=\"7210\"\u003e\n\u003cp data-end=\"7345\" data-start=\"7212\"\u003eAEDL gene-expression activation (\u003cstrong data-end=\"7269\" data-start=\"7245\"\u003eMUC4, MUC5AC, SFTPA1\u003c\/strong\u003e) in bronchial epithelium context: \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7477\" data-start=\"7346\"\u003e\n\u003cp data-end=\"7477\" data-start=\"7348\"\u003eADEL\/AEDL preclinical lung pathology model claims (inflammation\/fibrosis\/toxic injury): \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7593\" data-start=\"7478\"\u003e\n\u003cp data-end=\"7593\" data-start=\"7480\"\u003eDNA thermostability \/ binding discussion used as mechanistic rationale:\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684843188562,"sku":null,"price":50.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/Bronchogen_20mg.png?v=1770834811","url":"https:\/\/sciencepeptideslab.com\/products\/bronchogen-20mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}